Skip to search formSkip to main contentSkip to account menu

ICI 164384

Known as: Estra-1,3,5(10)-triene-7-undecanamide, N-butyl-3,17-dihydroxy-N-methyl-, (7alpha,17beta)-, ICI 164 384, ICI-164384 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

EstradiolEstrogen AntagonistsPolyunsaturated Alkamides
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Enhancement of the antitumor efficacy of the antiprogestin, onapristone, by combination with the antiestrogen, ICI 164384
So far, no combination of endocrine treatments has been routinely used in the therapy of breast Cancer. It was, therefore, our… 
1996
1996
The rat endometrial adenocarcinoma cell line RUCA-I: a novel hormone-responsive in vivol/in vitro tumor model
1996
1996
Effects of tamoxifen and ICI 164384 on protein synthesis and vectorial secretion in polarized rat uterine epithelial cells
1995
1995
The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines.
We investigated the effect of a concomitant treatment of ICI 164384 and B-interferon (beta-IFN) on the growth of estrogen… 
1994
1994
Pure anti-oestrogens (ICI 164384 and ICI 182780) and breast cancer: is the attainment of complete oestrogen withdrawal worthwhile?
INTRODUCTION The last decade has seen the emergence of a new class of pharmacological agents termed pure antioestrogens (Wakeling… 
1994
1994
The oestrogen receptor modulates growth of pituitary tumour cells in the absence of exogenous oestrogen.
The GH3 pituitary cell line has been used to investigate the role of the oestrogen receptor (ER) as a modulator of mitogenic… 
1991
1991
Circumvention of doxorubicin resistance in multi-drug resistant human leukaemia and lung cancer cells by the pure antioestrogen ICI 164384.
Highly Cited
1989
Highly Cited
1989
Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle.
Tamoxifen and other structurally related nonsteroidal antiestrogens possess properties in addition to their estrogen antagonist… 
Highly Cited
1989
Highly Cited
1989
Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells.
Non-steroidal antioestrogens, such as tamoxifen, inhibit the growth of human breast cancer cells. The experiments described here… 
Highly Cited
1989
Highly Cited
1989
Contrasting ability of antiestrogens to inhibit MCF-7 growth stimulated by estradiol or epidermal growth factor.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)